A small molecular agent YL529 inhibits VEGF-D-induced lymphangiogenesis and metastasis in preclinical tumor models in addition to its known antitumor activities

Youzhi Xu, Yinglan Zhao, Peng Yang et al.|BMC Cancer|2015

Cited by 5